Lindsey Trickett
Investor Relations Contact en F-STAR THERAPEUTICS, INC. .
Cargos activos de Lindsey Trickett
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - | - |
Historial de carrera de Lindsey Trickett
Antiguos cargos conocidos de Lindsey Trickett.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | 07/09/2017 | - |
Formación de Lindsey Trickett.
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 2 |
Operativa
| Investor Relations Contact | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Empresas privadas | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Lindsey Trickett
- Experiencia
